ABL1 and myeloproliferative disorder: Although the JAK2 V617F mutation has been frequently identified in BCR/ABL-negative MPN and is rarely present in other hematologic disorders, this mutation does occur in other hematologic malignancies, such as refractory anemia with ring sideroblast, AML and systemic mastocytosis (12,13).